The Archive · 2 posts

Allergy Therapeutics PLC

Pioneering allergy solutions! 🌿 Allergy Therapeutics (AGY) leads the charge in allergy treatment innovation on the LSE. 💊 Discover more today!

SubscribeRSS JSON

Allergy Therapeutics Reports Strong H1 Growth and Launches First New Immunotherapy in 20 Years in Germany

Allergy Therapeutics reports 7% H1 revenue growth and launches first new German immunotherapy in 20 years, Grassmuno.

January 19, 2026

Trending

Browse All

Investing

Allergy Therapeutics Reports Stable FY2025 Results with Key Pipeline Catalysts Ahead

Steady FY2025 results mask Allergy Therapeutics' explosive potential: German Grass MATA MPL approval & VLP Peanut data set to redefine allergy markets in 2025. (136 chars)

JoshuaJuly 21, 2025

Got an investment you want to share?

Let's Go